Suggestions
Jonathan Waldstreicher, MD
Founder & CEO at Galvanize Therapeutics
Jonathan Waldstreicher, MD, is the Founder and CEO of Galvanize Therapeutics, Inc., a biomedical company specializing in innovative therapies using Pulsed Electric Field (PEF) technology. He has been leading Galvanize since its inception in March 2022 and is based in Redwood City, California. The company focuses on developing medical devices aimed at treating various conditions, particularly in interventional oncology and pulmonology, with a notable product for chronic bronchitis currently undergoing clinical trials.124
Professional Background
Dr. Waldstreicher has a rich background in the medical device and pharmaceutical sectors, accumulating over 25 years of experience. Before founding Galvanize, he held several significant roles:
- Partner at Apple Tree Partners since May 2013.
- Founder and CEO of Galaxy Medical from March 2020 to March 2022.
- He also established Gala Therapeutics and served as its CEO from October 2015 to March 2022.23
His earlier career included positions at Johnson & Johnson, where he worked as Director of Emerging Technologies, and he completed a surgery internship at Tufts Medical Center. His educational background includes a dual MD/MBA from Tufts University School of Medicine, along with a BA in Economics from Brandeis University.23
Current Focus
Under Dr. Waldstreicher's leadership, Galvanize Therapeutics aims to expand its market presence, having already established its technologies in approximately 70 US hospitals and treated around 3,000 patients through clinical trials and commercial applications. The company is also actively working on new product developments and expanding clinical indications for its existing technologies.145
Dr. Waldstreicher's vision emphasizes the importance of innovative solutions in treating complex medical conditions, aiming to improve patient outcomes through advanced therapeutic technologies.14
Highlights
Congratulations to Dr. Justin Thomas and his team at Eisenhower Health on completing their first endoscopic ablation with the INUMI Flex needle, the first endoscopic #PEF ablation device! We are excited to partner with them in energizing patient care with this new technology.
Visit GalvanizeTX.com to learn more!
#INUMI #Aliya #PulsedElectricField #InterventionalRadiology #InterventionalPulmonology #InterventionalOncology
The Aliya® PEF System and the INUMI™ Flex needle are 510(k) cleared in the United States for the surgical ablation of soft tissue. They are not currently commercially available in any other geography.
Galvanize Therapeutics® does not promote the off-label use of its products and nothing herein is intended to promote an off-label use of the Aliya System. The Aliya System is a tool for the surgical ablation of soft tissues, and is not intended to treat, cure, prevent or mitigate any specific disease or condition.
Very proud that our Galvanize Therapeutics, Inc. team has completed 1,000 procedures using #Aliya #PEF! Thank you to the leaders who have advanced healthcare by using this novel technology. You have changed the lives of so many patients, and we are excited to continue partnering with you!
Interested in learning more about the #Aliya PEF System? Whether you plan to use the device percutaneously or endoscopically, we’ve got you covered. Visit https://lnkd.in/gjHWgiJE!
#INUMIFlex #PulsedElectricFields #MIS #iPeeps #InterventionalRadiology #InterventionalOncology #InterventionalPulmonology #Pulmonology #iRAD #MedEd #TwittIR #MedTwitter
The Aliya® PEF System and the INUMI Flex needle are 510(k) cleared in the United States for the surgical ablation of soft tissue. They are not currently commercially available in any other geography.
Galvanize Therapeutics® does not promote the off-label use of its products and nothing herein is intended to promote an off-label use of the Aliya System. The Aliya System is a tool for the surgical ablation of soft tissues, and is not intended to treat, cure, prevent or mitigate any specific disease or condition.
